The Hydration Pharmaceuticals Co (ASX:HPC) Cash-to-Debt : 0.18 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is The Hydration Pharmaceuticals Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. The Hydration Pharmaceuticals Co's cash to debt ratio for the quarter that ended in Jun. 2024 was 0.18.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, The Hydration Pharmaceuticals Co couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2024.

The historical rank and industry rank for The Hydration Pharmaceuticals Co's Cash-to-Debt or its related term are showing as below:

ASX:HPC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.18 Med: 0.87 Max: No Debt
Current: 0.18

During the past 3 years, The Hydration Pharmaceuticals Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.18. And the median was 0.87.

ASX:HPC's Cash-to-Debt is ranked worse than
68.85% of 305 companies
in the Retail - Defensive industry
Industry Median: 0.44 vs ASX:HPC: 0.18

The Hydration Pharmaceuticals Co Cash-to-Debt Historical Data

The historical data trend for The Hydration Pharmaceuticals Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

The Hydration Pharmaceuticals Co Cash-to-Debt Chart

The Hydration Pharmaceuticals Co Annual Data

Trend

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

1.26

0.47

The Hydration Pharmaceuticals Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash-to-Debt	Get a 7-Day Free Trial			No Debt	1.26	0.47	0.47	0.18

Competitive Comparison of The Hydration Pharmaceuticals Co's Cash-to-Debt

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Hydration Pharmaceuticals Co's Cash-to-Debt Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's Cash-to-Debt falls into.

The Hydration Pharmaceuticals Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

The Hydration Pharmaceuticals Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.701	/	(0	+	5.714)
	=	0.47

The Hydration Pharmaceuticals Co's Cash to Debt Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.854	/	(0	+	4.702)
	=	0.18

The Hydration Pharmaceuticals Co (ASX:HPC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

The Hydration Pharmaceuticals Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of The Hydration Pharmaceuticals Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

The Hydration Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » The Hydration Pharmaceuticals Co Ltd (ASX:HPC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121

Website

https://www.hydralyte.com

The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.

The Hydration Pharmaceuticals Co Headlines

No Headlines